PFIZER INC 4

Pfizer Chairman & CEO Albert Bourla received 24 phantom stock units linked to Pfizer common stock as a small, routine deferred compensation award while maintaining ownership of 786,154 common shares.

On July 31, 2026, Pfizer Inc. Chairman & CEO Albert Bourla acquired 24 phantom stock units under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, with each unit representing one phantom share of common stock and to be settled in cash following his separation from service. The phantom units, recorded at a reference price of about $24–$25.01 per unit, increased his deferred-equity-linked interest while his directly held common stock position remained at 786,154 shares. Using the current stock price of approximately $25.09, his post-transaction common stock holdings are worth roughly $19.7 million, and the incremental phantom unit award is de minimis in dollar terms and appears to be routine deferred compensation.

Filing Facts

CIK

78003

Ticker

PFE

Form

4

Source Type

fda

Accession

0001225208-26-006900

Alert Tier

4